Why the study?
Does receiving an 'at-risk' result from Type 2 diabetes screening increase anxiety or reduce well-being compared to a normal result in non-diabetic siblings of patients with established diabetes?
Does receiving an 'at-risk' result from Type 2 diabetes screening increase anxiety or reduce well-being compared to a normal result in non-diabetic siblings of patients with established diabetes?
Screening for Type 2 diabetes in high-risk individuals does not lead to sustained anxiety or reduced well-being at 1 year, regardless of whether the test result is normal or indicates increased risk.
Answers are grounded in this paper and cite their sources.
May support psychological safety of diabetes screening in high-risk families; leaves open need for randomized confirmation.
BACKGROUND: Targeted screening for Type 2 diabetes has been proposed as a method of identifying people with, or at risk of, the disease in order to implement preventive care. AIM: To assess the changes in anxiety, well-being, and cognitions associated with screening for Type 2 diabetes in people at increased risk of diabetes after 1 year; and to identify potential predictors of increased anxiety and lower well being over this period. DESIGN AND SETTING: One-year follow up of a cohort of non-diabetic siblings of those with Type 2 diabetes registered with general practitioners in Oxfordshire and Northamptonshire who were identified for participation in a programme to undertake sib-pair genetic analysis. METHODS: Potential families were selected through identification of people with Type 2 diabetes. Family members aged 35-74 years, who did not have diabetes and who were willing to participate in the study, completed measures before receiving the results of a fasting plasma glucose test, and 1 year later. Measures included the Spielberger State Anxiety Scale-short form (SSAI-SF), the Well-Being Questionnaire 12 item scale (WBQ-12), and measures of cognitions about developing diabetes. The Health Anxiety Inventory (HAI) was completed before receiving the results of the tests to assess its relationship with anxiety at 1 year. RESULTS: A cohort of 431 individuals was identified, of whom 328 (76%) returned fully completed WBQ scales both initially and at 1 year. State anxiety measured with the SSAI-SF fell from 34.5 (95% CI 33.4-35.6) to 32.3 (31.2-33.4) at 1 year (P < 0.0001). Mean WBQ-12 scores rose (i.e. improved) from 26.8 (26.0-27.4) to 27.4 (26.7-28.1) (P = 0.008). SSAI-SF and WBQ-12 mean scores over 1 year did not differ between participants receiving a normal or an at-risk test result. However, those receiving an at-risk test result were more likely, at 1 year, to consider themselves at increased likelihood of developing diabetes (P < 0.001) and to report thinking about what it would be like to develop diabetes (P = 0.006). A score in the upper tertile of the initial HAI was associated with an increased level of anxiety at 1 year (adjusted odds ratio 2.0, 95% CI 1.2-3.4, P = 0.006). CONCLUSIONS: There is no evidence that an 'at-risk' test result leads to sustained anxiety or reduced well being at 1 year compared with those receiving a normal test result. However, further studies are required to clarify levels of anxiety prior to screening to assess the overall impact of the process.
No takes yet. Share an insight, caveat, or question.
Farmer et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: